Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion type Assertion NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_head.
- NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion wasGeneratedBy ECO_0000203 NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_provenance.
- NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion wasDerivedFrom befree-20150227 NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_provenance.
- NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion SIO_000772 17148761 NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_provenance.
- NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion evidence source_evidence_literature NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_provenance.
- NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_assertion description "[Sequential treatment with paclitaxel followed by HGS-ETR1 or HGS-ETR2 after 48 h resulted in markedly enhanced antitumor activity against Colo205 mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815957.RAxo885xCmYWluJx0MKBulI0tFZxz2UC790oUVQ4GwvVg130_provenance.